1. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial. Issue 10 (October 2020) Authors: DiNardo, Courtney D; Maiti, Abhishek; Rausch, Caitlin R; Pemmaraju, Naveen; Naqvi, Kiran; Daver, Naval G; Kadia, Tapan M; Borthakur, Gautam; Ohanian, Maro; Alvarado, Yesid; Issa, Ghayas C; Montalban-Bravo, Guillermo; Short, Nicholas J; Yilmaz, Musa; Bose, Prithviraj; Jabbour, Elias J; Takahashi, ... Journal: Lancet Issue: Volume 7:Issue 10(2020) Page Start: e724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma. Issue 6 (3rd June 2017) Authors: Holkova, Beata; Yazbeck, Victor; Kmieciak, Maciej; Bose, Prithviraj; Ma, Shuo; Kimball, Amy; Tombes, Mary Beth; Shrader, Ellen; Wan, Wen; Weir-Wiggins, Caryn; Singh, Amanda; Hogan, Kevin T.; Conine, Sarah; Sankala, Heidi; Roberts, John D.; Shea, Thomas C.; Grant, Steven Journal: Leukemia & lymphoma Issue: Volume 58:Issue 6(2017) Page Start: 1349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase II study of omacetaxine mepesuccinate for patients with higher‐risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents. Issue 1 (15th November 2018) Authors: Short, Nicholas J.; Jabbour, Elias; Naqvi, Kiran; Patel, Ami; Ning, Jing; Sasaki, Koji; Nogueras‐Gonzalez, Graciela M.; Bose, Prithviraj; Kornblau, Steven M.; Takahashi, Koichi; Andreeff, Michael; Sanchez‐Petitto, Gabriela; Estrov, Zeev; Dinardo, Courtney D.; Montalban‐Bravo, Guillermo; Konopleva... Journal: American journal of hematology Issue: Volume 94:Issue 1(2019:Jan.) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms. Issue 2 (27th November 2017) Authors: Assi, Rita; Kantarjian, Hagop M.; Garcia‐Manero, Guillermo; Cortes, Jorge E.; Pemmaraju, Naveen; Wang, Xuemei; Nogueras‐Gonzalez, Graciela; Jabbour, Elias; Bose, Prithviraj; Kadia, Tapan; Dinardo, Courtney D.; Patel, Keyur; Bueso‐Ramos, Carlos; Zhou, Lingsha; Pierce, Sherry; Gergis, Romany; Tuttl... Journal: American journal of hematology Issue: Volume 93:Issue 2(2018:Feb.) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure. Issue 1 (6th December 2017) Authors: Alhuraiji, Ahmad; Naqvi, Kiran; Huh, Yang O.; Ho, Coty; Verstovsek, Srdan; Bose, Prithviraj Journal: Clinical case reports Issue: Volume 6:Issue 1(2018) Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Advances in potential treatment options for myeloproliferative neoplasm associated myelofibrosis. (3rd October 2019) Authors: Bose, Prithviraj Journal: Expert opinion on orphan drugs Issue: Volume 7:Number 10(2019) Page Start: 415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era. (6th April 2021) Authors: Shah, Mithun V.; Saliba, Rima M.; Varma, Ankur; Ciurea, Stefan O.; Oran, Betul; Olson, Amanda; Bose, Prithviraj; Bashir, Qaiser; Masarova, Lucia; Alousi, Amin M.; Srour, Samer; Mehta, Rohtesh S.; Daver, Naval; Pemmaraju, Naveen; Verstovsek, Srdan; Champlin, Richard E.; Popat, Uday R. Journal: British journal of haematology Issue: Volume 193:Number 5(2021) Page Start: 1004 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Approach to patients with essential thrombocythaemia and very high platelet counts: what is the evidence for treatment?. (16th December 2016) Authors: Falchi, Lorenzo; Bose, Prithviraj; Newberry, Kate J.; Verstovsek, Srdan Journal: British journal of haematology Issue: Volume 176:Number 3(2017) Page Start: 352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Association of gene mutations with time‐to‐first treatment in 384 treatment‐naive chronic lymphocytic leukaemia patients. (26th June 2019) Authors: Hu, Boyu; Patel, Keyur P.; Chen, Hsiang‐Chun; Wang, Xuemei; Luthra, Rajyalakshmi; Routbort, Mark J.; Kanagal‐Shamanna, Rashmi; Medeiros, L. Jeffrey; Yin, C. Cameron; Zuo, Zhuang; Ok, Chi Y.; Loghavi, Sanam; Tang, Guilin; Tambaro, Francesco P.; Thompson, Philip; Burger, Jan; Jain, Nitin; Ferrajoli... Journal: British journal of haematology Issue: Volume 187:Number 3(2019) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Avapritinib for Systemic Mastocytosis. Issue 8 (3rd August 2021) Authors: Bose, Prithviraj; Verstovsek, Srdan Journal: Expert review of hematology Issue: Volume 14:Issue 8(2021) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗